MWG, Minus Two Units, Posts 35-Percent Decline in Revenues for H1; Restructuring to Continue | GenomeWeb

NEW YORK, July 29 (GenomeWeb News) - MWG Biotech today reported a sharp downturn in revenues and a widening loss for the first half of 2005.

 

MWG Biotech also said it is still restructuring but did not provide details.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.